IP Library Granted Patent US 8,399,624
Granted Patent B1
US 8,399,624 · App. 12/823,488 · Granted Mar 19, 2013

Acceptor framework for CDR grafting

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,399,624
App. No.
12/823,488
Granted
Mar 19, 2013
Kind
B1
Abstract

The present invention relates to an antibody acceptor framework and to methods for grafting non-human antibodies, e.g., rabbit antibodies, using a particularly well suited antibody acceptor framework. Antibodies generated by the methods of the invention are useful in a variety of diagnostic and therapeutic applications.

Claims (10)

1. An immunobinder specific to a desired antigen comprising:

(a) a light chain acceptor framework comprising the three variable light chain CDRs of a lagomorph immunobinder specific for said desired antigen; and

(b) a human heavy chain acceptor framework comprising SEQ ID NO: 1 and the three variable heavy chain CDRs of said lagomorph immunobinder.

2. The immunobinder of claim 1 , wherein the light chain acceptor framework has at least 85% identity to SEQ ID NO: 2.

3. The immunobinder of claim 1 , further comprising a linker sequence that links the variable light chain acceptor framework and the heavy chain acceptor framework, wherein the linker sequence is SEQ ID NO: 4.

4. The immunobinder of claim 1 , further comprising light chain donor framework residues involved in antigen binding.

5. The immunobinder of claim 1 , wherein the immunobinder is a scFv antibody, a full-length immunoglobulin or a Fab fragment.

6. A humanized immunobinder specific for a desired antigen comprising:

(a) the three heavy chain CDRs of a donor rabbit immunobinder specific for said desired antigen grafted into a human heavy chain acceptor framework comprising SEQ ID NO: 1; and

(b) the three light chain CDRs of said donor rabbit immunobinder grafted into a light chain acceptor framework having at least 85% identity to SEQ ID NO: 2.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →
CHANGE OF NAME Recorded Jul 18, 2022
From: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
To: ESBATECH, A NOVARTIS COMPANY LLC
Reel/Frame 060529/0545 →
SECURITY INTEREST Recorded Jul 7, 2021
From: CELL MEDICA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056782/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED ON REEL 024931 FRAME 0219. ASSIGNOR(S) HEREBY CONFIRMS THE ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC. Recorded Sep 25, 2010
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 025042/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2010
From: ESCHER, DOMINIK
To: ALCON RESEARCH, LTD.
Reel/Frame 024931/0219 →